Publications

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

In the time-to-event analysis, the rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke among patients with type ...

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

Bariatric Surgery

Effective weight loss was achieved in morbidly obese patients after undergoing bariatric surgery. A substantial majority of patients with diabetes, hyperlipidemia, hypertension,...

Prevalence of the Metabolic Syndrome Among US Adults

These results from a representative sample of US adults show that the metabolic syndrome is highly prevalent. The large numbers of US residents with the metabolic syndrome may h...

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

Objective: To determine whether tight control of blood pressure prevents macrovascular and microvascular complications in patients with type 2 diabetes.

A metagenome-wide association study of gut microbiota in type 2 diabetes

Heart Disease and Stroke Statistics—2016 Update

Author(s): Writing Group Members; Mozaffarian, Dariush; Benjamin, Emelia J; Go, Alan S; Arnett, Donna K; Blaha, Michael J; Cushman, Mary; Das, Sandeep R; de Ferranti, Sarah; Des...

Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions

On a shelf in the sunny, open‐plan office of Cochrane Australia in Melbourne, there's a large, white ring‐binder that, it's fair to say, hasn't been opened in a while. It's a pr...

Targeting HIF-1 for cancer therapy

The bactericidal effect of silver nanoparticles

Nanotechnology is expected to open new avenues to fight and prevent disease using atomic scale tailoring of materials. Among the most promising nanomaterials with antibacterial ...

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

In this trial of apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin significantly reduced the incidence...